Effect of Statins on Skeletal Muscle Function

Parker, Beth A., Capizzi, Jeffrey A., Grimaldi, Adam S., Clarkson, Priscilla M., Cole, Stephanie M., Keadle, Justin, Chipkin, Stuart, Pescatello, Linda S., Simpson, Kathleen, White, C. Michael, Thompson, Paul D.·2013·Circulation
DOI 10.1161/circulationaha.112.136101

Cited by (501)

Items 401–500 of 501

  1. Statins, LDL-C and Beyond: A Contemporary Review of Atherosclerotic Cardiovascular Risk Assessment and Management
    Andrew James Fancher, Angel López‐Candales, Khalid Sawalha · 2026 · Journal of Lipid and Atherosclerosis
  2. Exercice physique intense, atteinte musculaire et prise de statines
    Éric Toussirot, Fabrice Michel, Nicolas F. Meneveau · 2014 · La Presse Médicale
  3. Statin myopathy: A problem looking for a solution
    Kenneth R. Feingold · 2015 · Atherosclerosis
  4. Statin Therapy in Hyperlipidemia: Balancing the Risk and Benefits
    Kenneth R. Feingold · 2014 · The Endocrine Society eBooks
  5. Objawy mięśniowe w przebiegu stosowania statyn — fakty, mity, rzeczywistość i stanowiska ekspertów
    Katarzyna Starzyk, Beata Wożakowska−Kapłon · 2015 · Folia Cardiologica
  6. Myopathies induites par les médicaments
    Abderrezak Khelfi, Mohammed Azzouz, Rania Abtroun, Mohammed Reggabi, Berkahoum Alamir · 2016 · Annales de Toxicologie Analytique
  7. The year in cardiology 2016: prevention
    Massimo Francesco Piepoli, Stefano Taddei, Ulrich Laufs · 2016 · European Heart Journal
  8. Statin Safety: What Every Health Care Provider Needs to Know
    Shamsudini Hashi, Vasanth Sathiyakumar, Kathleen Byrne, Mohamed Badreldin Elshazly, Steven Richard Jones, Seth Shay Martin · 2018 · Current Cardiovascular Risk Reports
  9. A Comparative Study of Muscle Symptoms of Atorvastatin with Rosuvastatin in Patients of Atherosclerotic Cardiovascular Disease
    Md Rakibul Hasan Rashed, Subhash Banerjee, Syed Ali Ahsan, SM Mustafa Zaman, Khurshed Ahmed, Md Mukhlesur Rahman, Manzoor Mahmood, Jahanara Arzu, Dipal Krishna Adhikary, Md Golam Hossain Rabbani et al. · 2018 · University Heart Journal
  10. Statins in real clinical practice: current guidelines, possibilities of new schemes for their use
    V. D. Sargsyan, T. V. Kamyshova, A. S. Safaryan, Н. М. Ахмеджанов, Д. В. Небиеридзе, Поддубская Елена Александровна · 2019 · Russian Journal of Preventive Medicine
  11. Definitions of Statin-Associated Muscle Symptoms
    Robert S. Rosenson · 2020 · Contemporary cardiology
  12. Statin Myopathy
    Jochen Schaefer, Sandra Jackson · 2016 · Springer eBooks
  13. The correlation of the efficacy and safety of statins with the aim of primary and secondary prevention: myths and reality
    Sergey R. Gilyarevsky, Maria V. Golshmid, Irina M. Kuzmina · 2015 · Systemic Hypertension
  14. ERUCA SATIVA MILL SEEDS OIL ALLEVIATES HYPERLIPIDEMIA AND NON-ALCOHOLIC FATTY LIVER DISEASE IN SYRIAN HAMSTER
    Mohammad Alhilal, Yaser A.M Sulaiman, A.M.H. Subuh, N Habra, Suzan Alhilal · 2022 · The Journal of Animal and Plant Sciences
  15. Association of lipid-lowering drugs with risk of sarcopenia: a drug target mendelian randomization study and meta-analysis
    Jiaxin Li, Chenyang Zang, Hui Lv, Zheng Xiao, Peihong Li, Bo Xiao, Luo Zhou · 2024 · Human Genomics
  16. Application of the Statin-Associated Muscle Symptoms-Clinical Index to a Cohort of Patients with Type 2 Diabetes Mellitus Undergoing Phlebotomy at an Endocrinology Clinic
    Nor Humaira Mohd Tajudin, Mathumalar Loganathan Fahrni, Rohana Abdul Ghani, Mohd Hazriq Awang, Hitesh Chopra, Ali Saleh Alkhoshaiban · 2024 · Journal of Pharmacology and Pharmacotherapeutics
  17. Statin-induced Myonecrosis—A Rare Adverse Effect of a Common Drug: A Case Report
    Hanna Demissie, Kemal Ali, Dagnaw Mersha, Salhadin Mohammed, Winny Costa Mapour, Biruktawit Michael, Desalegn Yayeh, Biniyam Alemayehu Ayele · 2025 · Sudan Journal of Medical Sciences
  18. Effects of Exercise on Lipid-Lipoproteins
    Beth A. Taylor, Amanda L. Zaleski, Paul D. Thompson · 2015 · Molecular and translational medicine
  19. Fettstoffwechselstörungen
    David Sinning, Ulf Landmesser · 2017 · Herz
  20. Sudden Creatine Kinase Elevation When an Athlete Starts Boxing: Looking Deeper Prior to Knocking the Statin Out
    Aakash A. Bavishi, Travis M. Howard, Amanda Rosen, Neil J. Stone · 2018 · The American Journal of Medicine
  21. Differenzialdiagnose der CK-Erhöhung
    Rudolf Andre Kley, Tobias Schmidt‐Wilcke, Matthias Vorgerd · 2018 · Aktuelle Neurologie
  22. Statin-Associated Muscle Symptoms Are Real
    Peter Paul Toth · 2020 · Contemporary cardiology
  23. Prevalence of SAMS in Observational and Clinical Trials
    Beth A. Taylor · 2020 · Contemporary cardiology
  24. Learning Adjustment Sets from Observational and Limited Experimental Data
    Sofia Triantafillou, Gregory F. Cooper · 2021 · Proceedings of the AAAI Conference on Artificial Intelligence
  25. The insidious impact of under-diagnosed proximal weakness induced by statins
    Bruce H. Dobkin · 2020 · Expert Review of Neurotherapeutics
  26. Atorvastatin-Induced Myalgia in Iranian Patients: A Hospital-Based Study to Determine the Prevalence and Associated Risk Factors
    Farzaneh Dastan, Jamshid Salamzadeh, Ali Saffaei, Yasaman Nabavi, Mohammad Abbasinazari · 2021 · Journal of Pharmaceutical Care
  27. SAMSON, SAMS and nocebo effects
    Jane K. Stock · 2021 · Atherosclerosis
  28. Resistance Training in Individuals With Hip and Knee Osteoarthritis: A Clinical Commentary With Practical Applications
    Michael F. Masaracchio, Kaitlin Kirker · 2022 · Strength and conditioning journal
  29. Statins for asthma
    Cho Min Naing, Han Ni · 2019 · Cochrane Database of Systematic Reviews
  30. A case of anti-HMGCR myopathy in a patient with breast cancer and anti-Th/To antibodies
    Mohammad Yassine Chérif, Ioannis Raftakis, Marjolaine Weynand, Elena Dragan, Carole Nagant, Sophie Lecomte, Valérie Badot · 2023 · Oxford Medical Case Reports
  31. Safety and efficacy of statins – Authors' reply
    Rory Collins, Jane Armitage, Colin Baigent, George Davey Smith, Liam L Smeeth · 2017 · The Lancet
  32. Efeitos do treinamento físico combinado periodizado e estatina em pessoas vivendo com HIV com dislipidemia: ensaio clínico randomizado, duplo-cego e placebo-controlado
    Hugo Ribeiro Zanetti · 2018
  33. Statin-Induced Musculoskeletal Problems: Disconcerting Reports and Data
    Antonis S. Manolis · 2015 · Hospital chronicles/Hospital Chronicles
  34. Facteurs de risque : muscle et statines
    Jean-Jacques Monsuez · 2013 · Archives des Maladies du Coeur et des Vaisseaux - Pratique
  35. Uncovering the mechanisms for statin‐mediated dysglycaemia: role of Rac1?
    Philip James Millar · 2015 · The Journal of Physiology
  36. Statin-induced Myopathy
    Anthony J. Dalby · 2017 · SA Heart
  37. Impact of Statins on Physical Activity and Fitness: Ally or Adversary?
    Charles Roberts · 2015
  38. The Effect of Vitamin D on Blood Pressure at Rest and in Response to a Peak Graded Exercise Test
    Braden Armstrong · 2016 · OpenCommons - UConn (University of Connecticut)
  39. Statin therapy for elderly patients should be assessed for each individual
    Raymond Gong · 2016 · Clinical Research in Practice The Journal of Team Hippocrates
  40. Nuggets of Knowledge: Statin-induced muscle weakness and falls
    Linda Julia M Bryant · 2014 · Journal of Primary Health Care
  41. Potion or Poison? Garlic
    Nataly Dominica Martini · 2014 · Journal of Primary Health Care
  42. Médicaments cardiovasculaires et performance physique
    François Carré · 2014 · Archives des Maladies du Coeur et des Vaisseaux - Pratique
  43. Opportunities for improving cardiovascular health outcomes in adults younger than 65 years with guideline‐recommended statin therapy
    Sara M. Sarasua, Jiexiang Li, Germán T. Hernández, Keith C. Ferdinand, Jonathan N. Tobin, Kevin A Fiscella, Daniel W. Jones, Angelo Sinopoli, Brent M. Egan · 2017 · Journal of Clinical Hypertension
  44. Update Dyslipidämien – Kommentar zur aktualisierten ESC/EAS-Leitlinie 2016
    David Sinning, Ulf Landmesser · 2017 · DMW - Deutsche Medizinische Wochenschrift
  45. Kommentar zu den neuen Leitlinien (2016) der European Society of Cardiology und European Atherosclerosis Society zur Diagnostik und Therapie der Dyslipidämien
    Ulf Landmesser, H. Gohlke, Rainer Hambrecht, Malte Kelm, Ulrich Laufs, Nikolaus Marx · 2017 · Der Kardiologe
  46. Exploration des myopathies toxiques : de l’anamnèse aux méthodes de pharmacogénomique
    Abderrezak Khelfi, Mohammed Azzouz, Rania Abtroun, Mohammed Reggabi, Berkahoum Alamir · 2017 · Annales de Toxicologie Analytique
  47. Cardiac CT in middle-aged athletes
    Thijs L. Braber · 2017 · Utrecht University Repository (Utrecht University)
  48. PCSK9 inhibition for primary prevention of ischaemic heart disease in heterozygous familial hypercholesterolaemia
    Aidan Ryan, Sarah J Nevitt, Christopher D. Byrne, Paul R. Cook · 2018 · Cochrane Database of Systematic Reviews
  49. Pharmacogenetics and Pharmacogenomics in Cardiovascular Medicine and Surgery
    Richard Myles Turner, Munir Pirmohamed · 2018 · Springer eBooks
  50. Commentary: Does my patient have statin associated muscle symptoms (SAMS)?
    Leo Di Giorgio, Michael Fleischmann · 2018 · International journal of osteopathic medicine
  51. Familiar hypercholesterolemia in high performance athletes: A case series and short clinical review
    Mindaugas Gudelis, Ricard Pruna · 2019 · Apunts Sports Medicine
  52. Statines, myalgies et rhabdomyolyse
    Anne Tournadre · 2019 · Revue du Rhumatisme
  53. Healthy Aging and Exercise: Preventing Disease and Disability
    Yin Wu, Gregory A. Panza, Beth A. Taylor, Linda Shannon Pescatello · 2019 · Springer eBooks
  54. Efficacité et effets indésirables des statines: évidences et polémiques
    Michel Komajda N · 2018 · Bulletin de l Académie Nationale de Médecine
  55. Statins in Females
    Velam Vanajakshamma, Latheef Kasala, Narendra Chanda · 2019 · Indian Journal of Cardiovascular Disease in Women
  56. Comparison of statin-induced myalgia between atorvastatin and rosuvastatin and among different duration of treatment groups: An observational study in a tertiary care hospital of West Bengal
    Prof. Abhijit Das · 2019 · Journal of Medical Science And clinical Research
  57. Consumo de estatinas y asociación con la elevación en los niveles de creatina fosfoquinasa
    Juan Manuel Toro-Escobar, Clara María Arango Toro, Germán Campuzano‐Maya, Diana P. Aranzazu-Botero, Óscar I. McEwen-Tamayo, Catalina Tobón-Ospina · 2015 · Medicina y Laboratorio
  58. The Role of Muscle Protein and Energy Metabolism in Statin-Associated Muscle Symptoms
    Paul Leonard Greenhaff, Joanne E. Mallinson, Flemming Dela · 2020 · Contemporary cardiology
  59. Clinical Management of SAMS
    Paul D. Thompson · 2020 · Contemporary cardiology
  60. The Effect of Statins on Exercise Performance and Exercise Training
    Gregory A. Panza, Paul D. Thompson · 2020 · Contemporary cardiology
  61. Statins and physical activity in human
    Anna Gawędzka, Malgorzata Elzbieta Knapik-Czajka, Jagoda Drąg · 2018 · Farmacja Polska
  62. Pharmacological prevention of ischemic stroke and tia : epidemiological aspects and how to improve treatment
    Lukas Geary · 2020 · Figshare
  63. Neue lipidsenkende Substanzen
    David Sinning, Ulf Landmesser · 2021 · DMW - Deutsche Medizinische Wochenschrift
  64. PHARMACOLOGICAL APPROACHES TO INCREASING THE EFFICIENCY OF TREATMENT OF CARDIOVASCULAR DISEASE
    Сергей Гаврилович Дзугкоев, Фира Соломоновна Дзугкоева, O.I. Margieva, I.V. Mozhaeva · 2021 · Современные проблемы науки и образования
  65. A SAMSON nyomán: statinintolerancia, nocebohatás, adherencia
    László Márk, István Reiber, László Bajnok, György Paragh · 2021 · Cardiologia Hungarica
  66. Statin-related myotoxicity
    Vera Fernandes, Maria Joana Santos, Antonio Pérez · 2016 · Endocrinología y Nutrición (English Edition)
  67. Introduction
    Beth A. Taylor, Paul D. Thompson · 2020 · Contemporary cardiology
  68. Statins increase muscle complaints, but do not impair performance
    2012 · Reactions Weekly
  69. Statin-updates
    Nandakumar Selvasudha, Kailasam Koumaravelou, Sridurga Devi N · 2017 · SM Analytical and Bioanalytical Techniques
  70. Médicaments cardiovasculaires et performance physique
    François Carré · 2014 · Science & Sports
  71. Hypocholesterolemic Potential of Momordica charantia Butanol Fraction on Albino Rats Fed High Fat Diet
    MK Atiku, A. Sani, B.G. Kurfi, S.Z. Bala, H.G. Ibraheem · 2022 · Bayero Journal of Pure and Applied Sciences
  72. The effect of atorvastatin therapy on skeletal muscle function in hyperlipidemia patients in khartoum
    Abdalla Eltoum Ali, Sitana Alkhwad Hassan Mohamed, Salma Abdallah Ali, Salih Abdelgadir Elmahdi · 2022 · International Journal of Biological and Pharmaceutical Sciences Archive
  73. Are Chronic Pain Syndromes the Reason for Statin-Associated Muscle Symptoms?
    Sheinin R, Nogueira AR, Bragazzi NL, ‬‬‬‬Abdulla Watad, Shmuel Tiosano, Gonen T, Yarden Yavne, Κassem Sharif, Y Kameri, Daniela Amital et al. · 2022 · Journal of Family Medicine
  74. Statin Myopathy
    Jochen Schaefer, Sandra Jackson · 2022 · Springer eBooks
  75. Specific Forms of Immune-Mediated Necrotizing Myopathies
    Balan Louis Gaspar · 2023 · Springer eBooks
  76. Evaluation of hypercholesterolemia management in at-risk patients by cardiologists in France: a case vignette-based study
    Jean Ferrières, Éric Bruckert, Michel Farnier, Michel Krempf, Jean‐Jacques Mourad, Baptiste Roux, François Schiele · 2023 · Journal of Comparative Effectiveness Research
  77. Association of Hyperlipidemia With Perioperative Complications in Posterior Cervical Spine Fusion
    Rintaro Okada, Seung Min Son, Zoë A. Fresquez, Blake G. Formanek, Kevin C. Mertz, Zorica Buser, Jeffrey C. Wang · 2023 · Clinical Spine Surgery A Spine Publication
  78. Highlights of the 31st Conference on Retroviruses and Opportunistic Infections (CROI), March 3–6, 2024 Denver, Colorado, USA
    Christina K. Psomas, Sabine Kinloch‐de Loes · 2024 · Journal of Virus Eradication
  79. Management of a patient at very high cardiovascular risk with myositis during high-intensity statin therapy
    Daria Yu. Sedykh, В. В. Кашталап, О. Л. Барбараш · 2024 · Meditsinskiy sovet = Medical Council
  80. The antihyperlipidemic effects of coenzyme Q10 and gemfibrozil on hyperlipidemic male rats: a comparative study
    Shahad MohamedAli, Shahad M. Khaleel, Doaa Khalid Ibrahim, Sadeel A. Shanshal · 2024 · Review of Clinical Pharmacology and Pharmacokinetics - International Edition
  81. Association of statins with peak oxygen consumption in 4,941 adults: A cross-sectional study
    Caio Eduardo Novaes, Eduardo Rondon, Caio Fernando Ribeiro Rizzo, Matheus Oscar de Oliveira, Francis Ribeiro de Souza, Maria Janieire de Nazaré Nunes Alves, Carlos Eduardo Negrão, Marcelo Rodrigues dos Santos · 2024 · IJC Heart & Vasculature
  82. Choosing the Optimal Non-Statin Lipid Lowering Therapies for Statin-Intolerant Patients: A Systematic Review and Network Meta-Analysis
    Wattakorn Laohapiboolrattana, Paisit Kosum, Mantiwee Nimworapan, Piyameth Dilokthornsakul, Kansak Boonpattharatthiti, Nonthikorn Theerasuwipakorn, Duangnapa Roongpiboonsopit, Pattamawan Kosuma, Teerapon Dhippayom · 2024 · SSRN Electronic Journal
  83. Bone metastases; clinical aspects
    Steven L. Wood, Ajitha Arikrishnan, Stella D’Oronzo, Janet Elizabeth Brown · 2025 · Elsevier eBooks
  84. Toxic Myopathies
    Jessica E. Hoogendijk · 2025 · Elsevier eBooks
  85. Statin use and muscle strength in older patients with heart failure
    Piotr Czapski, Wiktoria Niegowska, Jan Domański, Aleksandra Witkowska, Jakub Wirkijowski, Paulina Woźniak, Katarzyna Januszewska, Małgorzata Kupisz-Urbańska, Ada Sawicka, Piotr Jankowski · 2025 · Polski Merkuriusz Lekarski
  86. Suspected statin-related adverse drug reactions: analysis of spontaneous reports in Hubei Province, China (2014–2022)
    H.-X. Wang, Hongyu Bi, Xiaofang Shangguan, Zherui Chen, Rui Huang, Xianglong Chen, Yuanxuan Cai · 2025 · Expert Opinion on Drug Safety
  87. Long-term Intake of Statins or Renin-Angiotensin-System Inhibitors and Their Association With Parameters of Sarcopenia in Older Persons
    Tansu M. I. Aydoğan, Sarah Toepfer, Dominik Spira, Reinhold Hugo Kreutz, Ilja Demuth · 2025 · medRxiv
  88. Choosing the optimal nonstatin lipid lowering therapies for statin-intolerant patients: A systematic review and network meta-analysis
    Wattakorn Laohapiboolrattana, Paisit Kosum, Mantiwee Nimworapan, Piyameth Dilokthornsakul, Kansak Boonpattharatthiti, Nonthikorn Theerasuwipakorn, Duangnapa Roongpiboonsopit, Pattamawan Kosuma, Teerapon Dhippayom · 2025 · Journal of clinical lipidology
  89. Musculoskeletal Disorders in Patients on Statin Therapy: Prospective and Observational Study at a Tertiary Care Hospital
    Mushtaq Ahmad Dangroo, Shamas Haris, Muzaffar Ahmad Bindroo, Fayaz Ahmad Sofi, Feroze A. Shaheen, Nahida Majid, Suhaib Shamas, Hilal Rather · 2025 · Journal of Clinical and Preventive Cardiology
  90. Additional file 2 of Association of lipid-lowering drugs with risk of sarcopenia: a drug target mendelian randomization study and meta-analysis
    Li, Jiaxin, Chenyang Zang, Lv, Hui, Xiao, Zheng, Li, Peihong, Bo Xiao, Luo Zhou · 2024 · Figshare
  91. Additional file 1 of Association of lipid-lowering drugs with risk of sarcopenia: a drug target mendelian randomization study and meta-analysis
    Li, Jiaxin, Chenyang Zang, Lv, Hui, Xiao, Zheng, Li, Peihong, Bo Xiao, Luo Zhou · 2024 · Figshare
  92. Atorvastatin suppresses high-risk colorectal adenomas via reprogramming of lipid metabolism and Inhibition of stemness
    W. L. Chen, Mengxiao Ge, Shuangyi Sun, Hanxiao Zhang, Zeqin Wang, Yumeng Guo, Zhongguang Luo · 2025 · Scientific Reports
  93. Lipophilic but not hydrophilic statin therapy improves cardiodynamics without affecting skeletal muscle morphology or function in geriatric Wistar rats
    Irena A. Rebalka, Razan Alshamali, Tiffany L. vanLieshout, Molly A. Gingrich, Matthew R. Marlatt, Vladimir Ljubicic, Jeremy A. Simpson, Thomas James Hawke · 2026 · PLoS ONE
  94. Force–time curve analysis and muscle histology in women aged 50–80 undergoing statin therapy: a pilot cross-sectional study
    Gabriel de Souza Zanini, Mariana Rotta Bonfim, Elvis de Souza Malta, Alexandre Daré de Almeida, Danilo A. Massini, Dalton Muller Pessôa Filho, Henrique Luiz Monteiro · 2026 · Sport Sciences for Health
  95. Statin use does not impair muscle health in older adults: findings from the SCOPE study
    Seyedeh Dalia Fazel, Lisanne Tap, Paolo Fabbietti, Andrea Corsonello, Robert Kob, Cornel Christian Sieber, Regina Roller‐Wirnsberger, Gerhard Hubert Wirnsberger, Ronit Ben-Romano, Itshak Melzer et al. · 2026 · Aging Clinical and Experimental Research
  96. Skeletal muscle toxicity and statins : role of mitochondrial adaptations
    François Singh · 2016 · theses.fr (ABES)
  97. Perceptions, Attitudes, and Experiences of Statin Therapy Among Master Athletes
    Reid A. Mitchell, Noah D. Boroditsky, Chloe M. Kugler, Julien Wiese, Saul Isserow, Barbara N. Morrison, Nathaniel Moulson, James McKinney · 2026 · The American Journal of Cardiology
  98. Sex Patterns of Statin Therapy and Multicomponent Exercise Training on Cardiorespiratory Fitness in Older Adults with Dyslipidemia: A 24-Month Cohort Study
    Liliana C. Baptista, Aristides M Machado-Rodrigues, Marco Antônio Rabelo da Silva, Elias de França, Raul A. Martins · 2026 · Sports
  99. Long-term intake of statins or renin-angiotensin system inhibitors: associations with sarcopenia-related parameters in older people
    Tansu M. I. Aydoğan, Sarah Toepfer, Dominik Spira, Reinhold Hugo Kreutz, Ilja Demuth · 2026 · GeroScience
  100. Dyslipidemia management in athletes: A comparative commentary on the 2026 ACC/AHA/Multisociety Guideline and contemporary sports cardiology recommendations
    Deen L. Garba, Sohail Zahid, Roger Scott Blumenthal, Lili A. Barouch · 2026 · American Journal of Preventive Cardiology